May 2019 Gk Mania
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Appointments 1. Shri Ram Janmabhoomi Tirtha Kshetra Trust
Appointments 1. Shri Ram Janmabhoomi Tirtha Kshetra Trust elected Mahant Nritya Gopal Das as its Chairman and vice-president of Vishwa Hindu Parishad (VHP) Champat Rai elected as General Secretary. Also, Former principal secretary to Prime Minister Narendra Modi Nripendra Misra has been chosen as the chairman of the Ram Temple Complex Development Committee 2. Debasish Panda has been appointed as new finance secretary of India, replacing Rajiv Kumar. 3. Rajiv Bansal is appointed as CMD of Disinvestment bound ailing airline Air India. 4. UK Govt appointed Indian. 4. Origin person Alok Sharma as minister in charge for UN climate talks in November 2020, known as COP26. 5. Albin Kurti is appointed as new Prime Minister of Republic of Kosovo (Southeast Europe). 6. Atul Kumar Gupta has been appointed as President of Institute of Chartered Accountants (ICAI) for 2020-21, with Nihar Niranjan Jambusaria as Vice President. 7. Bhaskar Khulbe & Amarjeet Sinha have been appointed as Advisor to Prime Minister. 8. Board of Control for Cricket in India (BCCI) appointed new members for its 3- member Cricket Advisory Committee(CAC). New Members are Madan Lal, Rudra Pratap Singh and Sulakshana Naik. Kapil Dev had recently resigned as CAC Chairman. 9. Credit information bureau TransUnion Cibil appointed Rajesh Kumar as its new MD and CEO. 10. Former Indian Cricketer Robin Singh appointed as director of cricket of United Arab Emirates. 11. Govt. appointed Sanjay Kothari as new Chief Vigilance Commissioner (CVC) and Bimal Julka as New Chief Information Commissioner (CIC). 12. Incumbent Ashraf Ghani is named winner of Afghanistan Presidential Elections 2019. -
General Knowledge ABBREVIATIONS a A.A.F
General Knowledge ABBREVIATIONS A A.A.F. Auxiliary Air Force A.A.S.U. All Asom Students Union A.C.D. Asian Co-operation Dialogue A.D.B. Asian Development Bank A.E.C. Atomic Energy Commission A.F.P.R.O. Action for Food Production A.I.C.C. All India Congress Committee A.I.D.W.A. All India Democratic Women’s Association A.I.D.S. Acquired Immune Deficiency Syndrome A.I.H.B. All India Handicrafts Board A.I.R. Annual Information Report A.J.T. Advanced Jet Trainer A.P.E.C. Asia-Pacific Economic Cooperation A.R.F. ASEAN Regional Forum A.S.E.A.N. Association of South-East Asian Nations A.S.L.V. Augmented Satellite Launch Vehicle A.U. African Union A.V.E.S. Acute Viral Encephalitic Syndrome A.W.A.N. Army Wide Area Network A.Y.U.S.H. Ayurveda, Yoga, Unani, Siddha and Homeopathy B B.A.R.C. Bhabha Atomic Research Centre B.C.C.I. Board of Control of Cricket in India/Bank of Credit and Commerce International B.C.G. Bacillus Calmette Guerin (Anti-T.B. vaccine) B.C.T.T. Bank Cash Transaction Tax B.O.A.C. British Overseas Airways Corporation B.P.O. Business Process Outsourcing BREAD Basic Research Education And Development (SOCIENTY) B.S.N.L. Bharat Sanchar Nigam Ltd. B.V.R.A.A.M. Beyond Visual Range Air-to-Air Missile C C.A. Chartered Accountant C.A.C. Capital Account Convertibility 4 | G.K. C.A.C.C.I. -
Ques Related to Asian Games
Ques Related to Asian Games • India ended its Asian Games भारत ने अपने एशियाई खेलⴂ के Campaign with how many gold अशभयान को ककतने स्वर्ण पदक के medals? साथ समाप्त ककया? a) 14 a) 14 b) 13 b) 13 c) 7 d) 15 c) 7 d) 15 ग मᴂ स्वर्णﴂ Who has become the first Indian एशियाई खेलⴂ मᴂ िूट • woman to win a gold medal in पदक जीतने वाली पहली भारतीय shooting at the Asian Games? मशहला कौन बन गई है? • a) Manu Baker b) Rahi Sarnobat a) मनु बेकर c) Anjum Moudgil b) राही सरनोबत जुम मौदशगलﴂd) Heena Sidhu c) अ d) हीना शस饍धू • Who became the first Indian एशियाई खेलⴂ मᴂ स्वर्ण पदक woman wrestler to win a gold जीतने वाली पहली भारतीय medal at the Asian Games? मशहला पहलवान कौन बनी? a) Geeta Phogat a) गीता फोग b) Vinesh Phogat b) शवनेि फोग c) Sakshi Malik d) Pooja Dhanda c) साक्षी मशलक डाﴂd) पूजा ढा • Which Indian became the first कौन सा भारतीय एशियाई खेलⴂ badminton player to win silver in मᴂ रजत जीतने वाला पहला Asian Games? ?न शखलाडी बन गया ﴂबैडमम धुﴂa) PV Sindhu a) पीवी मस b) Saina Nehwal b) साइना नेहवाल c) Srikanth Kidambi बीﴂत ककदाﴂd) HS Prannoy c) श्रीका d) एचएस प्रर्य • Who has become the first Indian एशियाड स्वर्ण जीतने वाला पहला javelin thrower to win an Asiad भारतीय भाला फᴂक शखलाडी कौन gold? बन गया है? a) Muhammed Anas a) मुह륍मद अनस हﴂदर पाल मसﴂb) Tajinder Pal Singh b) तमज c) Dutee Chand दﴂd) Neeraj Chopra c) दुती च d) नीरज चोपडा • Who is the first Indian to win an मशहला䴂 के हेꥍ ाथलॉन Asiad gold in the women's प्रशतयोशगता मᴂ एशियाड स्वर्ण heptathlon event? जीतने वाले पहले भारतीय कौन a) Soma Biswas हℂ? b) Dutee Chand a) सोमा शवश्वास दﴂc) Swapna Barman b) -
Download Program Guide
2011 C. elegans Meeting Organizing Committee Co-chairs: Oliver Hobert Columbia University Meera Sundaram University of Pennsylvania Organizing Committee: Raffi Aroian University of California, San Diego Ikue Mori Nagoya University Jean-Louis Bessereau INSERM Benjamin Podbilewicz Technion Israel Institute of Keith Blackwell Harvard Medical School Technology Andrew Chisholm University of California, San Diego Valerie Reinke Yale University Barbara Conradt Dartmouth Medical School Janet Richmond University of Illinois, Chicago Marie Anne Felix CNRS-Institut Jacques Monod Ann Rougvie University of Minnesota David Greenstein University of Minnesota Shai Shaham Rockefeller University Alla Grishok Columbia University Ahna Skop University of Wisconsin, Madison Craig Hunter Harvard University Ralf Sommer Max-Planck Institute for Bill Kelly Emory University Developmental Biology, Tuebingen Ed Kipreos University of Georgia Asako Sugimoto RIKEN, Kobe Todd Lamitina University of Pennsylvania Heidi Tissenbaum University of Massachusetts Chris Li City College of New York Medical School Sponsored by The Genetics Society of America 9650 Rockville Pike, Bethesda, MD 20814-3998 telephone: (301) 634-7300 fax: (301) 634-7079 e-mail: [email protected] Web site: http:/www.genetics-gsa.org Front cover design courtesy of Ahna Skop 1 Table of Contents Schedule of All Events.....................................................................................................................4 Maps University of California, Los Angeles, Campus .....................................................................7 -
CTRI Trial Data
PDF of Trial CTRI Website URL - http://ctri.nic.in Clinical Trial Details (PDF Generation Date :- Tue, 28 Sep 2021 15:39:14 GMT) CTRI Number CTRI/2009/091/001080 [Registered on: 28/06/2010] - Last Modified On Post Graduate Thesis Type of Trial Type of Study Study Design Randomized, Parallel Group, Placebo Controlled Trial Public Title of Study A clinical Trial to study the safety, immunogenicity and tolerability of a tetravalent rotavirus vaccine in Indian infants. Scientific Title of Phase I/II, randomized, double-blind, placebo-controlled, dosage selection (10e5.5 or 10e6.25 FFU Study of each constituent serotype per 0.5 mL) study to evaluate the safety, tolerability, and immunogenicity of a 3-dose series of Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine [BRV-TV] administered to healthy Indian infants. Secondary IDs if Any Secondary ID Identifier NCT01061658 ClinicalTrials.gov SBL/BRV-TV/Form1/PhI/2009/0100 Protocol Number SBL/BRV-TV/Form1/PhI/2009/0100 Protocol Number Details of Principal Details of Principal Investigator Investigator or overall Name Dr. Gagandeep Kang Trial Coordinator (multi-center study) Designation Affiliation Address Department of Gastrointestinal Sciences, Christian Medical College Vellore TAMIL NADU 632004 India Phone 0416-2282052 Fax 0416-2282486 Email [email protected] Details Contact Details Contact Person (Scientific Query) Person (Scientific Name Dr. Raman Rao Query) Designation Affiliation Shantha Biotechnics Limited Address VP, R&D, 4th Floor, Vasantha Chambers, Fateh Maidan Road, Basheer Bagh Hyderabad ANDHRA PRADESH 500004 India Phone 040-66301800 Fax 040-23234133 Email [email protected] Details Contact Details Contact Person (Public Query) Person (Public Query) Name Dr. -
Exploring Nsr100/SRRM4 As a Therapeutic Target for Autism Spectrum Disorder in Mice
Exploring nSR100/SRRM4 as a therapeutic target for autism spectrum disorder in mice by Juli Wang A thesis submitted in conformity with the requirements for the degree of Master of Science Department of Molecular Genetics University of Toronto © Copyright by Juli Wang, 2019 I Exploring nSR100/SRRM4 as a Therapeutic Target for ASD in Mice Juli Wang Master of Science Department of Molecular Genetics University of Toronto 2019 Abstract Misregulation of nSR100 and its target microexons are common in a large proportion of ASD patients and cause ASD-associated features in mice. This thesis explores nSR100 and its target splicing program as a potential therapeutic target using a conditional knockout allele, nSR100GT. I show that nSR100 protein is effectively depleted in the cortical regions of nSR100GT mutant mice at E17.5, E18.5, and P2 stages, which correlates with phenotypes overlapping with all core behavioral domains of ASD. I show that tamoxifen-mediated rescue in prenatal nSR100GT animals restores nSR100 protein and microexon inclusion levels comparable to those observed in wildtype mice. Collectively my thesis research shows that the nSR100GT mouse strain holds the promise for examining phenotypic effects of nSR100 reactivation in ASD-like mice at different developmental stages, and complimentary models are also to be considered for investigating the therapeutic potential of targeting nSR100 in the context of ASD. II Acknowledgments I wholeheartedly thank for the tremendous support and educational experiences I have received from my mentors, -
Current Affairs Quiz – August, September & October for IBPS Exams
Current Affairs Quiz – August, September & October for IBPS Exams August - Current Affairs Quiz: Q.1) The Rajya Sabha passed the Constitution Q.8) Who came up with a spirited effort to beat _____ Bill, 2017 with amendments for setting up Florian Kaczur of Hungary and finish second in of a National Commission for Backward Classes, the Czech International Open Chess tournament was passed after dropping Clause 3. at Pardubidze in Czech Republic? a) 121st b) 122nd c) 123rd a) Humpy Koneru b) Abhijeet Gupta d) 124th e) 125th c) Vishwanathan Anand d) Harika Dronavalli Q.2) From which month of next year onwards e) Tania Sachdev government has ordered state-run oil companies Q.9) Which country will host 2024 summer to raise subsidised cooking gas, LPG, prices by Olympics? four rupees per cylinder every month to eliminate a) Japan b) Australia c) India all the subsidies? d) France e) USA a) January b) February c) March Q.10) Who beats Ryan Harrison to claim fourth d) April e) May ATP Atlanta Open title, he has reached the final in Q.3) Who will inaugurate the two-day Conclave of seven of eight editions of the tournament, added Tax Officers ―Rajaswa Gyansangam‖ scheduled to a fourth title to those he won in 2013, 2014 and be held on 1st and 2nd September, 2017 in New 2015? Delhi? a) Roger Federer b) Nick Kyrgios a) Arun Jaitley b) Narendra Modi c) Andy Murray d) John Isner c) Rajnath Singh d) Nitin Gadkari e) Kevin Anderson e) Narendra Singh Tomar Q.11) Who was the youngest of the famous seven Q.4) The Executive Committee of National Mission ‗Dagar Bandhus‘ and had dedicated his life to for Clean Ganga (4th meeting) approved seven keeping the Dhrupad tradition alive, died projects worth Rs _____ crore in the sector of recently. -
Investigation of Antibiotic Targets in the Decaprenyl
INVESTIGATION OF ANTIBIOTIC TARGETS IN THE DECAPRENYL-PHOSPHORYLARABINOSE BIOSYNTHESIS IN M. TUBERCULOSIS by SZILVIA TÓTH a thesis submitted to University of Birmingham for the degree of DOCTOR OF PHILOSOPHY School of Biosciences College of Life and Environmental Sciences University of Birmingham July 2018 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. Declaration The work presented in this thesis is original except where citing relevant references. Studies were conducted from 2014 to 2017 in the School of Biosciences, University of Birmingham, B15 2TT, UK and also in research and development facility of GlaxoSmithKline, laboratory for Diseases of the Developing World, Tres Cantos, Spain. No part of this work has been submitted for a degree or a diploma to this or any other university. ii Abstract An estimated 1.67 million people died of tuberculosis (TB) in 2016 and it is a threat to human life on a global-scale. To shorten current treatments and battle drug resistant strains it is important to discover and develop new drugs against the causative agent, Mycobacterium tuberculosis. Phenotypic screens have delivered potent hit and lead molecules in the past but the need to target new pathways in M. -
“Women Rarely Put Themselves Forward Despite Being Very Capable.”
IN CONVERSATION “Women rarely put themselves forward despite being very capable.” Professor Gagandeep Kang is currently the Executive Director of Translational Health Science and Technology Institute (THSTI), Faridabad. She is the first Indian woman scientist to be elected as Fellow of Royal Society (FRS) by the Royal Society in the UK. She is a leading scientist with over 300 scientific research papers published on diarrhoeal infections in children, mainly from work done at the Christian Medical College (CMC) in Vellore. Amongst several awards, she is the recipient of the Infosys Life Sciences Award in 2016. She is a member of many review and advisory committees for national and international funding agencies related to public health. Dr. Kang has chaired the WHO SEAR’s Regional Immunization Technical Advisory Group since 2015. In an interview given to PARUL R. SHETH for Science Reporter, Dr Gagandeep Kang talks about her work on rotaviruses, safety of Indian vaccines, the advantages and disadvantages of being a woman in science, and her experiences with community health programmes. 20 | Science Reporter | June 2019 GAGANDEEP KANG: My colleague, Ira and I published a PARUL R. SHETH: Congratulations to you for being the paper a couple of years ago, comparing children of doctors and first woman scientist to be elected as FRS in 360 years! This children who lived in urban slum areas, showing that middle indeed is a great honour and we are all proud of you. Your class Indian children carry in their guts one-fourth the number work has been recognised for its quality and impact. -
Annual Meeting
Volume 97 | Number 5 Volume VOLUME 97 NOVEMBER 2017 NUMBER 5 SUPPLEMENT SIXTY-SIXTH ANNUAL MEETING November 5–9, 2017 The Baltimore Convention Center | Baltimore, Maryland USA The American Journal of Tropical Medicine and Hygiene The American Journal of Tropical astmh.org ajtmh.org #TropMed17 Supplement to The American Journal of Tropical Medicine and Hygiene ASTMH FP Cover 17.indd 1-3 10/11/17 1:48 PM Welcome to TropMed17, our yearly assembly for stimulating research, clinical advances, special lectures, guests and bonus events. Our keynote speaker this year is Dr. Paul Farmer, Co-founder and Chief Strategist of Partners In Health (PIH). In addition, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, will deliver a plenary session Thursday, November 9. Other highlighted speakers include Dr. Scott O’Neill, who will deliver the Fred L. Soper Lecture; Dr. Claudio F. Lanata, the Vincenzo Marcolongo Memorial Lecture; and Dr. Jane Cardosa, the Commemorative Fund Lecture. We are pleased to announce that this year’s offerings extend beyond communicating top-rated science to direct service to the global community and a number of novel events: • Get a Shot. Give a Shot.® Through Walgreens’ Get a Shot. Give a Shot.® campaign, you can not only receive your free flu shot, but also provide a lifesaving vaccine to a child in need via the UN Foundation’s Shot@Life campaign. • Under the Net. Walk in the shoes of a young girl living in a refugee camp through the virtual reality experience presented by UN Foundation’s Nothing But Nets campaign. -
Badminton Association of India Welcomes Prime Minister's Initiative
Badminton Association of India welcomes Prime Minister’s initiative to enhance performance in Olympics By : INVC Team Published On : 27 Aug, 2016 10:19 PM IST INVC NEWS New Delhi, BAI President Dr. Akhilesh Das Gupta to support the initiative with all resources Badminton Association of India (BAI) welcome Prime Minister Narendra Modi's vision of achieving success in Olympics wherein he has announced setting up a Task Force to prepare a comprehensive action plan for effective participation of Indian sportspersons in the next three Olympic Games — 2020, 2024 and 2028. Praising Prime Minister’s initiative, Badminton Association of India’s President, Dr. Akhilesh Das Gupta stated, “I appreciate Prime Minister’s thought to prepare effective action plan to enhance performance of Indian sportsperson in future Olympics. I believe Shri Narendra Modi is the first Indian Prime Minister who is serious and has vision to improve the status of Indian sports. BAI welcomes his initiative and will support it with all our resources. BAI is open to work with Prime Minister Office and Sports Ministry to achieve success in Badminton in upcoming Olympics.” With BAI’s extensive support and training facilities, shuttler PV Sindhu and national coach P Gopichand clinched first Silver medal in Badminton discipline in the Olympics. BAI organises various youth level tournaments across the country as well as nurture young talents by conducting camps and supporting local badminton academies. BAI hosts two prestigious international tournaments - India Open BWF World Superseries and Syed Modi BWF Grand Prix Gold - to bring top-rated international players in India to compete with local players. -
Quotes on Rotavirus Vaccine News
Additional statements on ROTASIIL® Phase 3 India clinical trial results It is important to have a new approach to look at rotavirus vaccine efficacy. Rotavirus vaccination in developing countries has always struggled with interpretation of efficacy through use of markers of seroconversion or reduction of death in the community. Both are erroneous because of babies being breastfed as well as high infant mortality under five years of age in certain geographic regions of India. Better indicators have been surrogate indicators, which reflect fewer admissions of children to the hospital related to rotavirus as well as a reduced stay in the hospital due to the same. These markers have worked well in Mexico and El Salvador. Prof. N.K. Ganguly, Former Director General, Indian Council of Medical Research; Visiting Professor of Eminence, Policy Center for Biomedical Research, Translational Health Science & Technology Institute, Faridabad, India India now has another rotavirus vaccine that is manufactured indigenously. This is a win for the children of the country as it will support the Government of India’s efforts to roll out the rotavirus vaccine across the country through the Universal Immunization Programme. Dr. M.K. Bhan, Former Secretary, Department of Biotechnology, Government of lndia I am delighted that India has another rotavirus vaccine. Scientific studies have shown that rotavirus vaccines are making a major public health impact. Swift and significant declines in hospitalizations and deaths due to rotavirus and all‐cause diarrhea have been observed in many of the countries that have introduced rotavirus vaccines into their national immunization programs. Dr. Gagandeep Kang, Executive Director of Translational Health Science & Technology Institute, Faridabad, India, and member of the ROTA Council Rotavirus is the most common cause of diarrhea and one of the leading cause of under‐five child mortality.